|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1992-10-30
|
|
pubmed:abstractText |
At the time of primary surgery, approximately 90% of all patients with breast cancer are free of metastases, but in the next 5 years almost 50% of them will relapse. We evaluated the significance of the presence of tumor cells in bone marrow of patients with primary breast cancer to investigate their predictive value for relapse.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1534-9
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:1403032-Adult,
pubmed-meshheading:1403032-Aged,
pubmed-meshheading:1403032-Aged, 80 and over,
pubmed-meshheading:1403032-Antibodies, Monoclonal,
pubmed-meshheading:1403032-Biopsy,
pubmed-meshheading:1403032-Bone Marrow,
pubmed-meshheading:1403032-Bone Neoplasms,
pubmed-meshheading:1403032-Breast Neoplasms,
pubmed-meshheading:1403032-Female,
pubmed-meshheading:1403032-Humans,
pubmed-meshheading:1403032-Middle Aged,
pubmed-meshheading:1403032-Neoplasm Metastasis,
pubmed-meshheading:1403032-Predictive Value of Tests,
pubmed-meshheading:1403032-Prognosis,
pubmed-meshheading:1403032-Regression Analysis
|
|
pubmed:year |
1992
|
|
pubmed:articleTitle |
Detection of tumor cells in bone marrow of patients with primary breast cancer: a prognostic factor for distant metastasis.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, University Hospital, Heidelberg, Germany.
|
|
pubmed:publicationType |
Journal Article
|
